Did you know?

May 8, 2023 · Axsome Therapeutics ( NASDAQ: AXSM) added ~6% pre-market after its Q1 2023 results on Monday as investors turned attention to sales of its newly approved depression therapy, Auvelity, during its ... 9 at 9™ – 02/27/23 https://marketscholars.com/2023/02/27/9-at-9-02-27-23/… via @MarketScholars #9at9 #premarket #gappers #movers #trending #stocks #buyouts # ...Fiscal Q2 2023 ended 6/30/23. Reported on 8/7/23. Get the latest Axsome Therapeutics Inc (AXSM) real-time quote, historical performance, charts, and other financial information to …If AXSM closes above 15, and if I see confirmation in a few days, it will likely print what I call, The Templar continuation. If a low single digit stock, motors through the 9 Dollar dipty do, and ...AXSM gets an overall rating of 84. That means it scores higher than 84 percent of stocks. Axsome Therapeutics Inc gets a 97 rank in the Biotechnology industry. Biotechnology is number 23 out of 148 industries.View the AXSM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Axsome Therapeutics Inc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on …Track Axsome Therapeutics Inc (AXSM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAug 23, 2021 · Shares of the Axsome Therapeutics, Inc. (AXSM) stock were soaring in the Pre-market following the release of the AXS-05 update. AXSM stock price saw a push of 24.58% to reach 28.86 a share at the time of this writing. The stock was also green in the previous trade and went up by 8.29% at closing. Let’s take a closer look at this stock. Pre-market stock trading coverage from CNN. View pre-market trading, including futures information for the S&P 500, Nasdaq Composite and Dow Jones Industrial Average.Track Axsome Therapeutics Inc (AXSM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors According to the issued ratings of 11 analysts in the last year, the consensus rating for Axsome Therapeutics stock is Moderate Buy based on the current 2 hold ratings and 9 buy ratings for AXSM. The average twelve-month price prediction for Axsome Therapeutics is $102.40 with a high price target of $180.00 and a low price target of $81.00.Business, Economics, and Finance. GameStop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla. CryptoFind the latest historical data for Axsome Therapeutics, Inc. Common Stock (AXSM) at Nasdaq.com.Complete Axsome Therapeutics Inc. stock information by Barron's. View real-time AXSM stock price and news, along with industry-best analysis. AXSM technical analysis. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Axsome Therapeutics, Inc. is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more. Auvelity ® 1Q 2023 net product sales of $15.7 million. Total 1Q 2023 net product sales of $28.6 million. Total 1Q 2023 revenue of $94.6 million, including Sunosi ® ex-U.S. license agreement ...Shares of the Axsome Therapeutics, Inc. (AXSM) stock were soaring in the Pre-market following the release of the AXS-05 update. AXSM stock price saw a push of 24.58% to reach 28.86 a share at the time of this writing. The stock was also green in the previous trade and went up by 8.29% at closing. Let’s take a closer look at this stock.Axsome Therapeutics (NASDAQ:AXSM) has risen ~14.5% in the pre-market after the company announced the FDA acceptance of its New Drug Application (“NDA”) for AXS-05 for the treatment of the ...Exelixis is an oncology specialist best known for its blockbuster cancer drug Cabometyx. For instance, Exelixis recently settled a patent litigation lawsuit with Teva Pharmaceuticals that will ...Apr 21, 2023 · Axsome Therapeutics (AXSM) Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Axsome Therapeutics today and set a price target of $84.00. The company’s shares closed last ... Key update since our initiation. Axsome Therapeutics, Inc. ( NASDAQ: AXSM) is a pharmaceutical company focusing on CNS products, with a pipeline including proprietary drug formulations and ...

Key update since our initiation. Axsome Therapeutics, Inc. ( NASDAQ: AXSM) is a pharmaceutical company focusing on CNS products, with a pipeline including proprietary drug formulations and ...2 days ago · Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock. NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (“Axsome” or the “Company”), a biopharmaceutical company developing and delivering novel therapies for the manageme... 3 months ago - GlobeNewsWire. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Market Activity Funds + ETFs News + Insights P/E & PEG Ratios AXSM Latest Pre Market Trades About Latest Pre-Market Trades Nasdaq provides market information opens daily from 4:15 A.M. ET to...

AXSM gets an overall rating of 84. That means it scores higher than 84 percent of stocks. Axsome Therapeutics Inc gets a 97 rank in the Biotechnology industry. Biotechnology is number 23 out of 148 industries.Warning: Use of undefined constant HTTP_USER_AGENT - assumed 'HTTP_USER_AGENT' (this will throw an Error in a future version of PHP) in /www/wwwroot/newzaaj.com/wp ...See the latest Axsome Therapeutics Inc stock price (NASDAQ:AXSM), related news, valuation, dividends and more to help you make your investing decisions.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Data is delayed at least 15 minutes. Nasdaq.com will report pre-mark. Possible cause: Pre-Market: 0.57 0.00 | 0.00 %. Oct 11, 2023 4:00 PM EDT | Currency in USD ... XNA.